COVID-19 mRNA vaccine-induced adverse effects: unwinding the unknowns

Ioannis P. Trougakos; Evangelos Terpos; Harry Alexopoulos; Marianna Politou; Dimitrios Paraskevis; Andreas Scorilas; Efstathios Kastritis; Evangelos Andreakos; Meletios A Dimopoulos

doi:10.1016/j.molmed.2022.07.008

Related publications

Article2022

Adverse effects of COVID-19 mRNA vaccines: the spike hypothesis

Ioannis P. Trougakos, Evangelos Terpos, Harry Alexopoulos, Marianna Politou, Dimitrios Paraskevis, Andreas Scorilas, Efstathios Kastritis, Evangelos Andreakos, Meletios A Dimopoulos

Letter2022

COVID-19 BNT162b2 mRNA vaccine for patients with type 2 diabetes mellitus

Stavroula Α. Paschou, Vangelis Karalis, Θεοδώρα Ψαλτοπούλου, Ioanna Charitaki, Aimilia D. Sklirou, Vassiliki A. Iconomidou, Vasiliki Vasileiou, Georgia Kassi, Andromachi Vryonidou, Alexander Kokkinos, Nikolaοs Tentolouris, Erifili Hatziaggelaki, Ioannis P. Trougakos, Evangelos Terpos, Meletios A Dimopoulos

Article2021

Clinical characteristics and prognostic factors of myocarditis associated with the mRNA COVID‐19 vaccine

Wongi Woo, Ah Young Kim, Dong Keon Yon, Seung Won Lee, Jimin Hwang, Louis Jacob, Ai Koyanagi, Min S. Kim, Duk Hwan Moon, Jo Won Jung, Jae Young Choi, Se Yong Jung, Lucy Youngmin Eun, Sungsoo Lee, Jae Il Shin, Lee Smith

Article2022

Thrombocytopenia in COVID‑19 and vaccine‑induced thrombotic thrombocytopenia

Styliani Geronikolou, Işıl Takan, Athanasia Pavlopoulou, Marina Mantzourani, George Chrousos

Letter2021

Why two doses of the BNT162b2 mRNA COVID-19 vaccine? A different strategy to speed up the vaccination process: single-dose of the BNT162b2 mRNA COVID-19 and other vaccines

Carlo La Vecchia, Stefano Centanni, Alberto Giovanni Gerli